Unfunded quality demand
On 1 December 2017, the Global Fund Board approved grants worth $2.83 billion from the 2017-2019 allocations. This is the largest amount approved in a single batch since the start of the new funding model.
TRP praises Uganda’s TB/HIV funding request to the Global Fund, but sends two matching funds requests back for iteration
In its review of Uganda’s TB/HIV funding request, the Technical Review Panel (TRP) praised the country for positioning the request as part of a more sustainable response, including a push to improve coordination with the private sector, and for scaling up interventions for key populations.
Bangladesh’s “ambitious, but realistic” TB funding request to the Global Fund receives positive reviews
The TB funding request submitted by the Bangladesh CCM received positive reviews from the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). The two grants emanating from the request were approved by the Board on 17 October. A total of $110.9 million was approved, reflecting the total TB allocation for Bangladesh of $97.9 million and an additional $13.0 million in catalytic matching funds.
The two TB/HIV grants to Malawi which the Board approved on 17 October do not differ significantly from the funding request, which was submitted on 20 March 2017. GFO detailed the contents of the request in an article in GFO 316 on 19 July.
If your country receives money from the Global Fund, and if you compare your country’s allocation in 2017-2019 with its allocation in 2014-2016, it is likely you will find that the amount for 2017-2019 is lower, sometimes significantly lower. This may be true whether you are looking at the full allocation for your country or at the allocations for individual components.
The Board has approved a methodology for determining the allocations for 2017-2019. The methodology does not differ significantly from the one used for the 2014-2016 allocations. The main differences are as follows:
At its meeting on 8–9 October, the Strategy, Investment and Impact Committee (SIIC) made decisions in four areas related to the new funding model (NFM): awarding of incentive funding, managing unfunded quality demand, health systems strengthening and TB/HIV collaboration. This article provides details.
The $278.9 million in early applicant funding approved for HIV in Zimbabwe will be combined with existing funding from a Round 8 HIV grant. The principal recipient (PR) for this grant is the United Nations Development Programme.
The Global Fund provided a narrative to explain the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the new funding. This article provides a summary of the comments.